In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

Neurobiology of Disease

Volumn 21, Issue 2, 2006, Pages 404-412

  Gerhard, Alexander ^a,e   Pavese, Nicola ^a   Hotton, Gary ^a   Turkheimer, Federico ^a   Es, Meltem ^a   Hammers, Alexander ^a,d   Eggert, Karla ^b   Oertel, Wolfgang ^b   Banati, Richard B ^a,c   Brooks, David J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Microglia; Neuroinflammation; Parkinson's disease; PET; PK11195

Indexed keywords

N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ADULT; AGED; ARTICLE; BRAIN REGION; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MALE; MICROGLIA; NEUROIMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 30744472146     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.08.002     Document Type: Article

References (44)

1. R.B. Banati Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation? J. Physiol. Paris 96 2002 289 299
2. R.B. Banati, and M.B. Graeber Surveillance, intervention and cytotoxicity: is there a protective role of microglia? Dev. Neurosci. 16 1994 114 127
3. R.B. Banati, R. Myers, and G.W. Kreutzberg PK ('peripheral benzodiazepine')-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia J. Neurocytol. 26 1997 77 82
4. 11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis Neurology 53 1999 2199 2203
5. R.B. Banati, J. Newcombe, and R.N. Gunn The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity Brain 123 2000 2321 2337
6. R.B. Banati, A. Cagnin, and D.J. Brooks Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury NeuroReport 12 2001 3439 3442
7. H. Braak, K. Del Tredici, and U. Rub Staging of brain pathology related to sporadic Parkinson's disease Neurobiol. Aging 24 2003 197 211
8. D.J. Brooks, E.P. Salmon, and C.J. Mathias The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET Brain 113 1990 1539 1552
9. A. Cagnin, D.J. Brooks, and A.M. Kennedy In-vivo measurement of activated microglia in dementia Lancet 358 2001 461 477
10. 11C](R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion Brain 124 2001 2014 2027
11. S.E. Daniel, and A.J. Lees Parkinson's Disease Society Brain Bank, London: overview and research J. Neural Transm., Suppl. 39 1993 165 172
12. B. Dubois, A. Slachevsky, and I. Litvan The FAB: a Frontal Assessment Battery at bedside Neurology 55 2000 1621 1626
13. K. Friston, A.P. Holmes, and K.J. Worsley Statistical parametric maps in functional imaging: a general linear approach Hum. Brain Mapp. 2 1995 189 210
14. 11C]PK11195 and positron emission tomography in patients after ischemic stroke NeuroReport 11 2000 2957 2960
15. 11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy Neurology 61 2003 686 689
16. A. Gerhard, J. Watts, and I. Trender-Gerhard In vivo imaging of microglial activation with [(11)C](R)-PK11195 PET in corticobasal degeneration Mov. Disord. 19 2004 1221 1226
17. A. Gerhard, J. Schwarz, and R. Myers Evolution of microglial activation in patients after ischemic stroke: a [(11)C](R)-PK11195 PET study Neuroimage 24 2005 591 595 (electronic publication 2004 Nov 18.)
18. W.R. Gibb Neuropathology of Parkinson's disease and related syndromes Neurol. Clin. 10 1992 361 376
19. M.B. Graeber, K. Bise, and P. Mehraein CR3/43, a marker for activated human microglia: application to diagnostic neuropathology Neuropathol. Appl. Neurobiol. 20 1994 406 408
20. R.N. Gunn, A.A. Lammertsma, and S.P. Hume Parametric imaging of ligand-receptor binding in PET using a simplified reference region model Neuroimage 6 1997 279 287
21. R.N. Gunn, A.A. Lammertsma, and V.J. Cunningham Parametric imaging of ligand-receptor interactions using a reference tissue model and cluster analysis. Quantitative functional brain imaging with positron emission tomography R. Carson 1998 Academic Press San Diego 401 406
22. A. Hammers, R. Allom, and M.J. Koepp Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe Hum. Brain Mapp. 19 2003 224 247
23. A. Hammers, M.J. Koepp, and M.P. Richardson Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients Brain 126 2003 1300 1318
24. K. Imamura, N. Hishikawa, and M. Sawada Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains Acta Neuropathol. (Berl.) 106 2003 518 526 (electronic publication. 2003 Sep. 25)
25. A. Kakita, H. Takahashi, and Y. Homma Lewy bodies in the cerebellar dentate nucleus of a patient with Parkinson's disease Pathol. Int. 44 1994 878 880
26. G.W. Kreutzberg Microglia: a sensor for pathological events in the CNS Trends Neurosci. 19 1996 312 318
27. A.A. Lammertsma, and S.P. Hume Simplified reference tissue model for PET receptor studies Neuroimage 4 1996 153 158
28. A.E. Lang, and J.A. Obeso Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough Lancet Neurol. 3 2004 309 316
29. J.W. Langston, L.S. Forno, and J. Tetrud Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine exposure (see comments) Ann. Neurol. 46 1999 598 605
30. P.L. McGeer, S. Itagaki, and B.E. Boyes Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1988 1285 1291
31. P.L. McGeer, C. Schwab, and A. Parent Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration Ann. Neurol. 54 2003 599 604
32. P.K. Morrish, G.V. Sawle, and D.J. Brooks An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease Brain 119 1996 585 591
33. P.K. Morrish, J.S. Rakshi, and D.L. Bailey Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET J. Neurol. Neurosurg. Psychiatry 64 1998 314 319
34. Y. Ouchi, E. Yoshikawa, and Y. Sekine Microglial activation and dopamine terminal loss in early Parkinson's disease Ann. Neurol. 57 2005 168 175
35. S. Pappata, M. Levasseur, and R.N. Gunn Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 Neurology 55 2000 1052 1054
36. C.S. Patlak, and R.G. Blasberg Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations J. Cereb. Blood Flow Metab. 5 1985 584 590
37. J.S. Rakshi, T. Uema, and K. Ito Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study Brain 122 1999 1637 1650
38. R.A. Robb, and D.P. Hanson A software system for interactive and quantitative visualization of multidimensional biomedical images Australas. Phys. Eng. Sci. Med. 14 1991 9 30
39. U. Rub, K. Del Tredici, and C. Schultz Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology Neurobiol. Aging 23 2002 245 254
40. T.J. Spinks, T. Jones, and P.M. Bloomfield Physical characteristics of the ECAT EXACT3D positron tomograph Phys. Med. Biol. 45 2000 2601 2618
41. C. Studholme, D.L. Hill, and D.J. Hawkes Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures Med. Phys. 24 1997 25 35
42. P. Teismann, K. Tieu, and O. Cohen Pathogenic role of glial cells in Parkinson's disease Mov. Disord. 18 2003 121 129
43. F.E. Turkheimer, C.B. Smith, and K. Schmidt Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data Neuroimage 13 2001 920 930
44. J. Wang, V.C. Asensio, and I.L. Campbell Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice Curr. Top. Microbiol. Immunol. 265 2002 23 48